首页> 外文期刊>Biotechnic and Histochemistry >The effects of kefir, koumiss, yogurt and commercial probiotic formulations on PPAR alpha and PPAR-beta/delta expressions in mouse kidney
【24h】

The effects of kefir, koumiss, yogurt and commercial probiotic formulations on PPAR alpha and PPAR-beta/delta expressions in mouse kidney

机译:Kefir,Koumiss,酸奶和商业益生菌制剂对小鼠肾脏PPARα和PPAR-Beta / delta表达的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Commercial probiotic capsules that contain probiotic bacteria, kefir, koumiss and yogurt contain beneficial microorganisms that affect cholesterol levels and immune response, and are used for treatment of some diseases. We investigated using immunohistochemistry the effects of kefir, koumiss, yogurt and a commercial probiotic formulation on the expression levels of peroxisome proliferator-activated receptor-alpha (PPAR alpha) and peroxisome proliferator-activated receptor-beta/delta (PPAR-beta/delta), which are members of the nuclear steroid hormone receptor superfamily in mouse kidney. Mice were assigned to five groups: group 1, commercial probiotic capsules; group 2, kefir; group 3, koumiss; group 4, yogurt; group 5, control. After oral administration for 15 days, body weights were recorded and kidney tissue samples were obtained. Hematoxylin & eosin staining and the streptavidin-biotin peroxidase complex (ABC) method were applied to tissue sections to examine histology and to determine the localization of PPAR alpha and PPAR-beta/delta in the kidneys. We found that the weights of the mice in the kefir, koumiss, yogurt and commercial probiotic capsules groups were increased compared to controls. No differences in kidney histology were observed in any of the experimental groups. Kefir, koumiss, yogurt and the commercial probiotic preparation increased PPAR alpha and PPAR-beta/delta expressions.
机译:含有益生菌的商业益生菌胶囊,Kefir,Koumiss和酸奶含有有益的微生物,这些微生物会影响胆​​固醇水平和免疫应答,用于治疗一些疾病。我们研究了免疫组织化学对凯菲尔,Koumiss,酸奶和商业益生菌制剂对过氧化物体增殖物激活的受体-α(PPARα)和过氧化物酶促增殖物激活的受体-β/ delta(PPAR-Beta / delta)的表达水平的影响,这是核类固醇激素受体超家族在小鼠肾脏的成员。将小鼠分配到五组:第1组,商业益生菌胶囊;第2组,Kefir;第3组,koumiss;第4组,酸奶;第5组,控制。在口服施用15天后,记录体重并获得肾组织样品。苏木辛和曙红染色和链霉抗生物素蛋白 - 生物素过氧化物酶复合物(ABC)方法施用于组织切片以检查组织学,并确定PPARα和PPAR-β/ delta的定位在肾脏中。我们发现与对照组相比,kefir,koumiss,酸奶和商业益生菌胶囊组的小鼠的重量增加。在任何实验组中观察到肾组织学没有差异。 Kefir,Koumiss,酸奶和商业益生菌制剂增加了PPARα和PPAR-Beta / delta表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号